Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 120, Issue 1, 2005, Pages 107-114

  Muslumanoglu, Hamza M ^a   Oner, U ^a   Ozalp, S ^a   Acikalin, M F ^a   Yalcin, O T ^a   Ozdemir, M ^a   Artan, S ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Comparative genomic aberrations; Endometrial carcinogenesis; Endometrial carcinoma; Endometrial hyperplasia; Genomic copy aberrations

Indexed keywords

PARAFFIN;

ARTICLE; CANCER GRADING; CHROMOSOME 10Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME MUTATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENETICS; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 18144372351     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.08.015     Document Type: Article

References (38)

1. R.J. Kurman Blaustein's pathology of the female genital tract 5th ed. 2002 Springer New York
2. G.L. Mutter, Baak JPA, and C.P. Crum Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry J Pathol 190 2000 462 469
3. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
4. S. Ozalp, Ö.T. Yalçin, N. Basaran, S. Kabukçuoǧ lu, and T. Minsin Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancer Eur J Gynaecol Oncol 21 2000 282 286
5. P.J. Goodfellow, B.M. Buttin, and T.J. Herzog Prevalence of defective DNA, mismatch repair and MSH6 mutation in an unselected series of endometrial cancers Proc Natl Acad Sci USA 100 2003 5908 5913
6. K. Helou, A. Walentinsson, and B. Beckmann Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization Cancer Genet Cytogenet 127 2001 118 127
7. M. Taskin, T.A. Lallas, H.R. Barber, and M.M. Shevchuk Bcl-2 and p53 in endometrial adenocarcinoma Mol Pathol 10 1997 728 734
8. B.M. Ronnett, R.T. Burks, K.R. Cho, and L. Hedrick DCC genetic alterations and expression in endometrial carcinoma Mod Pathol 10 1997 38 46
9. A.S. Elhafey, J.C. Papadimitriou, M.S. El-Hakim, A.I. El-Said, B.B. Ghannam, and S.G. Silverberg Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic and malignant endometrium Arch Pathol Lab Med 125 2001 872 879
10. T. Enomoto, M. Fujita, and M. Inoue Alterations of the p53 tumor suppressor gene and its association with activation of the K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium Cancer Res 53 1993 1883 1888
11. S. Ozalp, O.T. Yalcin, H.M. Tanir, S. Kabukcuoglu, and G. Erol p53 overexpression as a prognostic indicator in endometrial carcinoma Eur J Gynaecol Oncol 24 2003 275 278
12. H. Pere, J. Tapper, T. Wahlstrom, S. Knuutila, and R. Butzow Distinct chromosome imbalances in uterine serous and endometrial carcinomas Cancer Res 58 1998 892 895
13. R. Muresu, M.C. Siri, and A. Cossu Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer Eur J Cancer 38 2002 1802 1809
14. S.M. Sirchia, E. Sironi, and F.R. Grati Losses of heterozygosity in endometrial adenocarcinomas: positive correlation with histopathological parameters Cancer Genet Cytogenet 121 2000 156 162
15. J.L. Benedet N.F. Hacker Ngan HYS Staging classifications and clinical practice guidelines of gynecologic cancers by FIGO Committee on Gynecologic Oncology and IGCS Guidelines Committee 2nd ed. 2000 Elsevier Science Canada
16. A. Arslantas, S. Artan, and U. Oner The importance of genomic copy number changes in the prognosis of glioblastoma multiforme Neurosurg Rev 27 2004 58 64
17. O. Henegariu, N.A. Heerema, L.L. Wright, P. Bray-Ward, D.C. Ward, and G.H. Vance Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing Cytometry 43 2001 101 109
18. M. Kiechle, M. Hinrichs, and A. Jacobsen Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization Am J Pathol 156 2000 1827 1833
19. R.J. Kurman, P.F. Kaminski, and H.J. Norris The behavior of endometrial hyperplasia. A long-term study of untreated hyperplasia in 170 patients Cancer 56 1985 403 412
20. K. Heselmeyer, E. Schrock, and S. du Manoir Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix Proc Natl Acad Sci USA 93 1996 479 484
21. T. Ried, K. Heselmeyer-Haddad, H. Blegen, E. Schrock, and G. Auer Genomic changes defining the genesis progression and malignancy potential in solid human tumors: a phenotype/genotype correlation Genes Chromosomes Cancer 25 1999 195 204
22. H. Baloglu, L.A. Cannizzaro, J. Jones, and L.G. Koss Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization Hum Pathol 32 2001 615 622
23. I. Ben-Porath, and N. Benvenisty Characterization of a tumor-associated gene, a member of a novel family of genes encoding glycoproteins Gene 183 1996 69 75
24. A. Wellmann, P. Flemming, and P. Behrens High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression Int J Mol Med 7 2001 489 494
25. G. Peiro, J. Diebold, G.B. Baretton, R. Kimmig, and U. Lohrs Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2 Bax and caspase-3 expression at outcome Int J Gynecol Pathol 20 2001 359 367
26. U. Brinkmann CAS, the human homologue of the blast chromosome segregation gene CSE1, in proliferation, apoptosis and cancer Am J Hum Genet 62 1998 509 513
27. D. Kong, A. Suzuki, and T.T. Zou PTEN is frequently mutated in primary endometrial carcinomas Nat Genet 17 1997 143 144
28. Y. Hirai, N. Tanaka, and R. Furuta Somatic mutations of the PTEN/MMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer Gynecol Oncol 83 2001 81 88
29. I.U. Ali Gatekeeper for endometrium: the PTEN tumor suppressor gene J Natl Cancer Inst 92 2000 861 863
30. G.L. Maxwell, J.I. Risinger, and C. Gumbs Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Cancer Res 58 1998 2500 2503
31. A. Suzuki, S. Fukushige, S. Nagase, N. Ohuchi, S. Satomi, and A. Horii Frequent gains on chromosome arms 1q and/or 8q in human endometrial cancer Hum Genet 100 1997 629 636
32. Y. Suehiro, K. Umayahara, and H. Ogata Genetic aberrations detected by comparative genomic hybridization to predict outcome in patients with endometrioid carcinoma Genes Chromosomes Cancer 29 2000 75 82
33. J.T. Li, W. Liu, and Z.H. Kuang Amplification of RIT1 in hepatocellular carcinoma and its clinical significance Ai Zheng 22 2003 695 699
34. H. Wolter, H.W. Gottfried, and T. Mattfeldt Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization BJU Int 89 2002 310 316
35. H. Moritake, T. Sugimoto, and H. Kuroda Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines Cancer Genet Cytogenet 146 2003 102 109
36. K. Heselmeyer-Haddad, V. Janz, and P.E. Castle Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia Am J Pathol 163 2003 1405 1416
37. I. Guilleret, P. Yan, L. Guillou, R. Braunschweig, J.M. Coindre, and J. Benhattar The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation Carcinogenesis 23 2002 2025 2030
38. H.J. Kwun, J.H. Lee, S. Min do, and K.L. Jang Transcriptional regression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2 FEBS Lett 544 2003 38 44